|
Fox, D; Smulian, A G (2001) Plasminogen-binding activity of enolase in the opportunistic pathogen Pneumocystis carinii. Med Mycol 39:495-507
|
|
Smulian, A G; Sullivan, D W; Theus, S A (2000) Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization. Microbes Infect 2:127-36
|
|
Fox, D; Smulian, A G (2000) Mkp1 of Pneumocystis carinii associates with the yeast transcription factor Rlm1 via a mechanism independent of the activation state. Cell Signal 12:381-90
|
|
Fox, D; Smulian, A G (1999) Mitogen-activated protein kinase Mkp1 of Pneumocystis carinii complements the slt2Delta defect in the cell integrity pathway of Saccharomyces cerevisiae. Mol Microbiol 34:451-62
|
|
Broomall, K R; Morris, R E; Walzer, P D et al. (1998) Zymolyase treatment exposes p55 antigen of Pneumocystis carinii. J Eukaryot Microbiol 45:284-9
|
|
Theus, S A; Smulian, A G; Steele, P et al. (1998) Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 16:1149-57
|
|
Theus, S A; Sawhney, N; Smulian, A G et al. (1998) Proliferative and cytokine responses of human T lymphocytes isolated from human immunodeficiency virus-infected patients to the major surface glycoprotein of Pneumocystis carinii. J Infect Dis 177:238-41
|
|
Smulian, A G; Keely, S P; Sunkin, S M et al. (1997) Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J Lab Clin Med 130:461-8
|
